Exclusive

Publication

Byline

Location

US Patent Issued to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGYCo., SHANGHAI BAOLONG PHARMACEUTICAL, BAOLONG PHARMACEUTICAL, SHANGHAI BAOLONG ANQING PHARMACEUTICAL on June 23 for "Safe and stable nimodipine formulation for injection and method for preparing same" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,344, issued on June 23, was assigned to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGYCo. LTD. (Shanghai), SHANGHAI BAOLONG PHARMACEUTICAL Co.... Read More


US Patent Issued to THE GEORGE INSTITUTE FOR GLOBAL HEALTH on June 23 for "Compositions for the treatment of hypertension" (Australian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,345, issued on June 23, was assigned to THE GEORGE INSTITUTE FOR GLOBAL HEALTH (Randwick, Australia). "Compositions for the treatment of hy... Read More


US Patent Issued to SIMCERE PHARMACEUTICAL on June 23 for "Anti-aging method comprising applying JWA gene" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,346, issued on June 23, was assigned to SIMCERE PHARMACEUTICAL Co. LTD. (Nanjing, China). "Anti-aging method comprising applying JWA gene" ... Read More


US Patent Issued to Dr. Falk Pharma on June 23 for "Systemic formulation of a pyridinone derivate for coeliac disease" (German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,347, issued on June 23, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany). "Systemic formulation of a pyridinone derivate for coelia... Read More


US Patent Issued to Dr. Falk Pharma, Zedira on June 23 for "Systemic formulation of a pyridinone derivate for TG2-related diseases" (German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,348, issued on June 23, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany) and Zedira GmbH (Darmstadt, Germany). "Systemic formulatio... Read More


US Patent Issued to LG CHEM on June 23 for "Pharmaceutically acceptable salt of sphingosine-1-phosphate receptor agonist, and crystalline form thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,349, issued on June 23, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Pharmaceutically acceptable salt of sphingosine-1-phosphate rec... Read More


US Patent Issued to Flex Pharma on June 23 for "Amorphous cabozantinib particles and uses thereof" (Minnesota Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,350, issued on June 23, was assigned to Flex Pharma LLC (New Brighton, Minn.). "Amorphous cabozantinib particles and uses thereof" was inve... Read More


US Patent Issued to INVENGENE on June 23 for "Stable liquid compositions of posaconazole" (Indian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,351, issued on June 23, was assigned to INVENGENE PRIVATE Ltd. (Mumbai, India). "Stable liquid compositions of posaconazole" was invented b... Read More


US Patent Issued to Memorial Shan-Ketering Cancer Center, Memorial Hospital for Cancer and Allied Diseases, Sloan-Kettering Institute for Cancer Research, Biosplice Therapeutics on June 23 for "Combination therapy with CLK/DYRK inhibitors and BCL2 inhibitors to treat leukemia" (New York, California Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,352, issued on June 23, was assigned to Memorial Shan-Ketering Cancer Center (New York), Memorial Hospital for Cancer and Allied Diseases (N... Read More


US Patent Issued to Yeda Research and Development on June 23 for "SPT5 inhibitors and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,353, issued on June 23, was assigned to Yeda Research and Development Co. Ltd. (Rehovot, Israel). "SPT5 inhibitors and uses thereof" was in... Read More